Crosstalk On Drug Pricing: Conflicts In Trump Team Rhetoric And Policy

The Trump Administration’s rhetoric and policy approaches illustrate the confusion that often arises between efforts to cut drug prices and cutting spending.

Many ideas to reduce drug pricing actually cut drug spending. (Shutterstock)
Key Takeaways
  • Policymakers often confuse reducing drug spending and drug pricing, including FDA Commissioner Martin Makary.

US Food and Drug Administration Commissioner Martin Makary’s favorite solution for high drug prices is to stop using so many.

More from Pricing Debate

More from Market Access